4//SEC Filing
Call Matthew 4
Accession 0001209191-21-050063
CIK 0001808865other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 7:55 PM ET
Size
7.1 KB
Accession
0001209191-21-050063
Insider Transaction Report
Form 4
Call Matthew
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-07-30$2.95/sh+53,672$158,332→ 53,672 total - Exercise/Conversion
Stock Option (right to buy)
2021-07-30−53,672→ 148,090 totalExercise: $2.95Exp: 2029-12-04→ Common Stock (53,672 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the stock option vest on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816207
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 7:55 PM ET
- Size
- 7.1 KB